Atalanta Therapeutics

Boston, MA · Founded 2018 · Privately Held (backing)

Developer of targeted RNA-modulating therapeutics designed for the treatment of genetically defined diseases. Atalanta Therapeutics is based in Boston, MA and was founded in 2018. Its last reported valuation was $45 million in Jun 2018. It has raised $227 million.

Last reported valuation

$45.0M

Oct 2026

Priced at

—

Total raised

$227.0M

Last round

—

How much has Atalanta Therapeutics raised?

$227.0Macross 0 recorded rounds

Free account

More of Atalanta Therapeutics with a free account

·The complete investor list: 11 names
·Watch Atalanta Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Atalanta Therapeutics investors

11 investors are on record for Atalanta Therapeutics, including F-Prime Capital, Mirae Asset Capital, EQT Life Sciences and Novartis Venture Fund.

For fundraisers

Raising for a company like Atalanta Therapeutics?

11 investors have backed Atalanta Therapeutics.

See all 11 investors →

Frequently asked about Atalanta Therapeutics

How much has Atalanta Therapeutics raised?: Atalanta Therapeutics has raised $227.0M in total across 0 recorded funding rounds.